We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+6.18%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.9B
AUM Growth
+$1.56B
(+7.6%)
Cap. Flow
+$486M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
19.94%
Holding
3,346
New
196
Increased
1,490
Reduced
1,397
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$43.6M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$39.6M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$36.1M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$35.4M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$32.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$41.5M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$36.1M |
| 3 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$27.3M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$22.9M |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.43% |
| 2 | Financials | 4.62% |
| 3 | Consumer Discretionary | 4.22% |
| 4 | Healthcare | 3.87% |
| 5 | Industrials | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Edison International
EIX
$26.7B
| $2.26M | 0.01% |
32,528
-1,616
| -5% | -$114K |
|
|
ZOM
1102
DELISTED
Zomedica Corp.
ZOM
| $2.25M | 0.01% |
11,257,560
+1,000
| +0% | +$203 |
|
1103
Nuveen Municipal Credit Income Fund
NZF
$2.42B
| $2.25M | 0.01% |
192,735
-5,402
| -3% | -$62.7K |
|
1104
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
| $2.23M | 0.01% |
98,350
-25,504
| -21% | -$591K |
|
1105
Intercontinental Exchange
ICE
$85B
| $2.23M | 0.01% |
19,729
+981
| +5% | +$106K |
|
|
JPUS
1106
JPMorgan Diversified Return US Equity ETF
JPUS
$467M
| $2.23M | 0.01% |
22,798
-218
| -0.9% | -$20.7K |
|
1107
Regions Financial
RF
$26.9B
| $2.23M | 0.01% |
124,927
-71,986
| -37% | -$1.27M |
|
1108
Sempra
SRE
$56.2B
| $2.21M | 0.01% |
30,432
+3,804
| +14% | +$286K |
|
1109
Keysight
KEYS
$60.6B
| $2.21M | 0.01% |
13,209
-2,951
| -18% | -$458K |
|
|
TPHE
1110
DELISTED
Timothy Plan High Dividend Stock Enhanced ETF
TPHE
| $2.21M | 0.01% |
97,167
+4,678
| +5% | +$108K |
|
1111
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.07B
| $2.21M | 0.01% |
90,175
+10,760
| +14% | +$266K |
|
1112
Entergy
ETR
$50.3B
| $2.21M | 0.01% |
45,352
+2,140
| +5% | +$111K |
|
1113
iShares Global Healthcare ETF
IXJ
$4.23B
| $2.21M | 0.01% |
25,938
+3,592
| +16% | +$306K |
|
1114
Royal Bank of Canada
RY
$297B
| $2.2M | 0.01% |
23,012
+453
| +2% | +$43.2K |
|
1115
BCE
BCE
$21.6B
| $2.19M | 0.01% |
48,126
+3,093
| +7% | +$144K |
|
1116
iShares Select U.S. REIT ETF
ICF
$2.09B
| $2.19M | 0.01% |
39,378
+11,355
| +41% | +$618K |
|
1117
Sony
SONY
$138B
| $2.19M | 0.01% |
121,455
+2,805
| +2% | +$52.6K |
|
1118
Innovator US Equity Power Buffer ETF May
PMAY
$818M
| $2.19M | 0.01% |
73,187
+5,646
| +8% | +$163K |
|
1119
DraftKings
DKNG
$12.7B
| $2.18M | 0.01% |
82,156
+2,260
| +3% | +$52.1K |
|
1120
US Global Jets ETF
JETS
$825M
| $2.17M | 0.01% |
101,236
-123,495
| -55% | -$2.32M |
|
1121
FT Vest US Equity Deep Buffer ETF September
DSEP
$355M
| $2.17M | 0.01% |
63,286
-42,967
| -40% | -$1.41M |
|
1122
First Trust Managed Futures Strategy Fund
FMF
$259M
| $2.16M | 0.01% |
45,245
+10,386
| +30% | +$497K |
|
1123
iShares ESG Advanced Universal USD Bond ETF
EUSB
$711M
| $2.15M | 0.01% |
50,618
-864
| -2% | -$37.1K |
|
1124
Invesco Financial Preferred ETF
PGF
$668M
| $2.15M | 0.01% |
149,986
+5,251
| +4% | +$75.8K |
|
1125
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
| $2.15M | 0.01% |
56,189
-12,424
| -18% | -$478K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Cambridge Investment Research Advisors held 3,346 positions worth $21.9B, up 7.6% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q2 2023 filing shows 196 new, 1,490 increased, 1,397 reduced and 181 closed positions. Its largest new stake was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $41.5M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q2 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M.
- Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $43.6M increase.
- Cambridge Investment Research Advisors's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $41.5M.
- Cambridge Investment Research Advisors fully exited AllianzIM U.S. Equity Buffer10 Jul ETF in Q2 2023, selling an estimated $9.73M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.9B portfolio in Q2 2023.
- Cambridge Investment Research Advisors opened 196 new positions and closed 181 in Q2 2023.
- Cambridge Investment Research Advisors's portfolio value rose 7.6% quarter-over-quarter to $21.9B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.